Video

The Concierge Pharmacist Model

Calvin Knowlton, BSc Pharm, MDiv, PhD, and CEO, Chairman, & Founder of Tabula Rasa Healthcare, discusses his model for the 'concierge pharmacist' and what it means for pharmacy profits. This video was filmed at the 2019 NCPA Annual Convention in San Diego.

Calvin Knowlton, BSc Pharm, MDiv, PhD: So, it’s kind of like chiropractic back in the day, where they started in the ‘70s and weren’t getting paid, then they showed their outcome and started being paid by commercial plans and the government now. We feel the same way. We feel that concierge pharmacists should just rely on people who can afford to pay cash on a monthly basis. You know, it won’t be that much, $35 to $40 a month. And they’ll be tethered to the pharmacist, and anytime they want to change anything they’ll have their own iPhone that has My MedWise in it, and the patient’s regimen for their father is in there, tethered to the pharmacy. And if they go to 7-11 to pick up something for sleep, you know, Tylenol PM, they can put it in there and it shows their risk score. They can contact the pharmacist to say ‘What else can I do?’ So that model of concierge is a very tight connection; it’s kind of Velcro for the pharmacist to the patient.

Related Videos
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
Image Credit: © Cavan - stock.adobe.com
Image Credit: © utah51 - stock.adobe.com
Image Credit: © Rawpixel.com - stock.adobe.com
Image Credit: © RandyJay - stock.adobe.com
Image Credit: © nimito - stock.adobe.com
WCLC, lung cancer, NSCLC
MARIPOSA Study: Long-Term Outcomes and Next Steps for Amivantamab Plus Lazertinib in EGFR-Mutant NSCLC
The EMPOWER-Lung 1 Trial: Five-Year Outcomes of Cemiplimab Monotherapy in Advanced NSCLC